Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • MGI Sues Illumina Again for Patent Infringement in the United States

    Oct 2, 2019, 12:13 PM by Michael Croft
    SAN JOSE, CA, UNITED STATES - Oct 2, 2019 - Complete Genomics, a U.S. affiliate of MGI, has filed a patent infringement counterclaim against Illumina in U
    Full story
  • Case For The Cloud: Balancing Robust Cybersecurity With Efficient Data Sharing

    Oct 2, 2019, 08:40 AM by Michael Croft

    Bio-IT World Contributed Commentary | Cybersecurity breaches are costly, from fines imposed by regulatory bodies to jeopardizing years of R&D investment if proprietary information falls into the wrong hands. With the volume of information generated during the development of pharmaceutical and biotechnology products increasing at a remarkable pace, many businesses are now investing in robust data management platforms to minimize the risks posed by cybercrime.

    Full story
  • BioIVT Appoints Global Business Strategist Lori Ball as Its Chief Operating Officer

    Oct 2, 2019, 08:27 AM by Michael Croft
    WESTBURY, NY - Oct 2, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Lori Ball as its chief operating officer (COO)
    Full story
  • AstraZeneca selects N-SIDE Suite for Clinical Trials to optimize and monitor clinical trial supply chain

    Oct 1, 2019, 05:35 AM by Michael Croft
    LOUVAIN LA NEUVE, BELGIUM - Oct 1, 2019 - N-SIDE, provider of innovative software and strategic consulting services, announced that AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials
    Full story
  • Dr Mark Truesdale joins Solentim as new Chief Marketing Officer

    Oct 1, 2019, 05:33 AM by Michael Croft
    BOURNEMOUTH, UK - Oct 1, 2019 - Solentim, the global leader in cell line development (CLD) instrumentation, is delighted to announce that Dr Mark Truesdale will join the Company as the new Chief Marketing Officer, effective immediately
    Full story
  • Nature reports that MR Solutions’ advanced preclinical imaging system helps researchers better understand the ageing processes

    Oct 1, 2019, 05:20 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Oct 1, 2019 - Research published in Nature by the Korea Advanced Institute of Science (KAIST) found that lymphatic vessels in the scull involved in the clearance of cerebrospinal fluid often become compromised with age
    Full story
  • X4 Pharmaceuticals Reports Positive Data from Phase 2a Trial of Mavorixafor in Combination with Axitinib in Advanced Clear Cell Renal Cell Carcinoma Patients

    Sep 30, 2019, 17:14 PM by Michael Croft
    BARCELONA, SPAIN - Sep 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced positive results from the Phase 2a portion of its open-label Phase 1/2 clinical trial of mavorixafor (X4P-001) in combination with axitinib (Inlyta®) in patients with advanced clear cell renal cell carcinoma (ccRCC)
    Full story
  • Signant Health Proudly Sponsors “DISORDER: The Rare Disease Film Festival” to Raise Awareness and Hope for Millions of Families Worldwide

    Sep 30, 2019, 09:54 AM by Michael Croft
    PHILADELPHIA, PA, UNITED KINGDOM - Sep 30, 2019 - There are 7,000 recognized rare disease conditions that affect between 25 and 30 million people in the United States alone, and the vast majority are totally unknown in the community
    Full story
  • Creative Enzymes Has Added Several New Services to 2019 Online Product Catalog

    Sep 29, 2019, 22:29 PM by Michael Croft
    SHIRLEY, NY - Sep 30, 2019 - With a high reputation among academic and industrial enzyme companies, Creative Enzymes has recently added three newly-developed enzyme services to 2019 product catalog, for researchers working in the life science field
    Full story
  • Lab Testing Services at BOC Sciences: Quick, Convenient and Cost-Effective

    Sep 29, 2019, 22:24 PM by Michael Croft
    LONG ISLAND CITY, NY, UNITED STATES - Sep 25, 2019 - The past decade has witnessed an upsurging demand for lab testing. Whether it's just a simple routine analysis of chemical and physical properties of compounds or specifying impurities, which is slightly more difficult, lab testing is necessary
    Full story
  • Peptide Library and Peptide Array Released by Creative Peptides: Useful Tools for Protein-Protein Interaction Research

    Sep 29, 2019, 22:20 PM by Michael Croft
    NEW YORK, NY, UNITED STATES - Sep 19, 2019 - As one of the world's leading peptide suppliers, the New York-based company Creative Peptides announced the release of peptide library and peptide array, providing powerful tools for scientists who are involved with protein–protein interaction research, drug R&D and many other possible applications associated with biochemicals and pharmaceuticals
    Full story
  • Creative Enzymes Has Brought up a Series of Upgraded Enzymes Services for Life Science Field

    Sep 29, 2019, 22:20 PM by Michael Croft
    SHIRLEY, NY - Sep 30, 2019 - As an excellent supplier and manufacturer, Creative Enzymes has recently upgraded several enzymes related services, such as enzyme expression and purification services, and enzyme engineering services, for researchers working in the life science or research field
    Full story
  • Creative Enzymes Upgrades Several Enzymes Services for Research and Industrial Use

    Sep 27, 2019, 04:46 AM by Michael Croft
    SHIRLEY, NY - Sep 27, 2019 - As an excellent supplier and manufacturer, Creative Enzymes has recently upgraded several enzymes related services, such as enzyme expression and purification services, and enzyme engineering services, for researchers working in the life science or research field
    Full story
  • Several New Services Have Been Added to 2019 Online Product Catalog by Creative Enzymes

    Sep 26, 2019, 22:22 PM by Michael Croft
    SHIRLY, NY - Sep 27, 2019 - With a high reputation among academic and industrial enzyme companies, Creative Enzymes has recently added three newly-developed enzyme services to 2019 product catalog, for researchers working in the life science field
    Full story
  • Stratio’s LinkSquare Brings The Power Of Infrared Spectroscopy To Scientific Research

    Sep 26, 2019, 13:54 PM by Michael Croft
    SAN JOSE, CA, UNITED STATES - Sep 26, 2019 - Stratio, Inc. launchedLinkSquare, a smart handheld spectrometer, attaining innovation in usability, cost and size, designed to simplify infrared spectroscopy and ready to help laboratories deliver lab results to the palm of your hand
    Full story
  • CRISPR-Cas9, IRBM, GenScript, and More: News From September 2019

    Sep 26, 2019, 10:55 AM by Michael Croft

    Bio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including CRISPR-Cas9, IRBM, GenScript, and more.

    Full story
  • Sharp appoints Sascha Sonnenberg as Global Head of Business Development, Sharp Clinical Services

    Sep 26, 2019, 04:30 AM by Michael Croft
    RHYMNEY, UK - Sep 26, 2019 - Sharp, a part of UDG Healthcare and a leading provider of clinical supply services, has strengthened its leadership team with the appointment of Sascha Sonnenberg as global head of business development for Sharp Clinical Supply Services
    Full story
  • Hammerspace Data-as-a-Service Protects and Secures Data Across the Hybrid Multi-Cloud

    Sep 25, 2019, 13:50 PM by Michael Croft
    MOUNTAIN VIEW, CA, UNITED STATES - Sep 25, 2019 - Hammerspace Data-as-a-Service Protects and Secures Data Across the Hybrid Multi-CloudA single platform serves and manages file data across any infrastructure, on-prem and on the cloudHammerspace, a software company smashing the complexity of how data is served and managed across the hybrid multi-cloud and containers, today announced enterprise hybrid cloud services for protecting and securing data
    Full story
  • FDA Renews Licenses for Synchrogenix’s GlobalSubmit Software to Review and Validate New Drug and Biologics Applications

    Sep 25, 2019, 08:08 AM by Michael Croft
    PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenix’s electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™ for another year
    Full story
  • Bio-IT World Welcomes Entries For 2020 Innovative Practices Awards

    Sep 25, 2019, 07:15 AM by Michael Croft
    Bio-IT World | Bio-IT World is accepting entries for the 2020 Innovative Practices Awards competition.
    Full story
  • «
  • 241
  • 242
  • 243 (current)
  • 244
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy